Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B

“A Terrible Beauty is a relatively short account of the origins and formation of NICE, originally the National Institute for Clinical Excellence, and of its first sixteen years of operations. Together with some assessment of its impact to date.” – Nicholas Timmins –

Abstract Real-world effectiveness studies are important for monitoring performance of COVID-19 vaccination programmes and informing COVID-19 prevention and control policies. We aimed to synthesise methodological approaches used in COVID-19 vaccine effectiveness studies, in order to evaluate which

Kittiphong Thiboonboon1 , Benjarin Santatiwongchai1 ,Varit Chantarastapornchit1 , Waranya Rattanavipapong1 , Yot Teerawattananon1 Abstract Background For more than three decades, the number and influence of economic evaluations of healthcare interventions have been increasing and gaining atte

A Systematic Review of Economic Evaluation Literature in Thailand. Are the Data Good Enough to be Used by Policy-Makers? Yot Teerawattananon1 Steve Russell2 Miranda Mugford3 1 International Health Policy Program, MInistry of Public Health, Nonthaburi, Thailand 2 School of Development Studie

This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under

Project Consultant Dr. Yot Teerawattananon and Dr. Wanrudee Isaranuwatchai      63191002RM018L0quarantine guideline

67196067RU034L6benefits package,Universal health coverage (UHC),National List of Essential Medicines (NLEM),Monitoring and evaluation,Policy development,Health system